
|Videos|April 22, 2020
Regulatory Hurdles for Increased Availability of Cannabis-Infused Edibles
Author(s)Total Pharmacy Team
Advertisement
Merril Gilbert, founder and CEO of TraceTrust: One is getting it declassified as a Schedule I narcotic. It’s clearly not that. There is no addictive qualities: it’s a combination of other things. But it’s also, again, how do I counteract it and not knowing how it’s going to react for different people. You’re going to have the same reaction as if you have a peanut allergy and we have to be really conscious of that. So, again, creating a standard like we’re doing in this same manner and together with other types of certifications –nonGMO and vegan– and really aligning together, raising up together and not competing against each other is crucial now.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Audits Demand Pharmacy Awareness, Compliance, and Proactive Defense
2
Metformin Cuts Long COVID Risk by Half in New ACTIV-6 Trial Results
3
How Will Emerging AI Impact the Pharmacy Benefit Manager Space?
4
How McKesson Advocates for Pharmacy Support and Sustainability
5









































